newsfilter
← Latest News
GlobeNewswire·

Kuehn Law Encourages Investors of Kymera Therapeutics, Inc. to Contact Law Firm

  • Kuehn Law, PLLC is investigating Kymera Therapeutics, Inc. (NASDAQ: KYMR) for potential fiduciary duty breaches & self-dealing by officers & directors.
  • Shareholders may be eligible for damages & corporate governance reforms resulting from the investigation.
  • Long-term KYMR stockholders can contact Justin Kuehn, Esq. at justin@kuehn.law or (833) 672-0814 for a free consultation.
  • Kuehn Law covers all case costs & charges no fees to investor clients.
  • Shareholders are urged to contact the firm immediately due to potential time limits on enforcing rights.